Respiratory and Anesthesia

Olympus achieves first treatment for severe emphysema using Spiration Valve System

Olympus Medical Systems has announced that a patient with severe emphysema has been treated using endobronchial valve treatment with FDA-approved Spiration Valve System (SVS).

Third Pole Therapeutics announces inhaled nitric oxide strategic collaboration with Actelion

Third Pole Therapeutics, a privately held company developing and delivering transformative cardio-pulmonary therapies, has entered into a strategic collaboration to work with Actelion Pharmaceuticals, a Janssen pharmaceutical company of Johnson & Johnson.

The Equivital healthcare wearable worn by US soldiers to avoid heat-related injury

Equivital has developed a healthcare wearable for the US military that can withstand environmental pressures to collect physiological data

El Camino Hospital first in California to offer new treatment for severe COPD/Emphysema

El Camino Hospital today announced it is the first hospital in California to have successfully performed the new and recently Food and Drug Administration (FDA) approved lung valve treatment for patients with severe COPD/emphysema, an incurable lung disease that causes extreme breathing difficulty and constant discomfort for patients.

Analysing why vaping is not a safe alternative to smoking and what other tech can help kick the habit

Given they contain many harmful chemicals, e-cigarettes may not be a healthy alternative to smoking but there is another type of tech that claims to be different

ResMed completes acquisition of HB Healthcare

ResMed, a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries, has completed the acquisition of HB Healthcare (HBH) to help millions of South Koreans living with sleep apnea, chronic obstructive pulmonary disease (COPD) and other respiratory conditions.

New Breath Biopsy breathalyser to speed cancer detection by measuring chemical compounds

The Breath Biopsy device is designed to diagnose cancer early from molecules exhaled by patients.

Medtronic-sponsored Microstream capnography study provides easy-to-use risk prediction tool

Medtronic has said that preliminary results from a prospective, multi-center study to identify patients at high risk for opioid-induced respiratory compromise offered easy-to-use risk prediction tool.

Vapotherm releases next generation of capital unit: Precision Flow Hi-VNI System

Vapotherm, a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI Technology products that are used to treat patients of all ages suffering from respiratory distress, announced the release of the next generation of its capital unit: the Precision Flow Hi-VNI system.